Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 1
1997 1
1998 2
1999 1
2000 8
2001 15
2002 51
2003 82
2004 110
2005 126
2006 128
2007 145
2008 253
2009 179
2010 259
2011 214
2012 213
2013 191
2014 231
2015 309
2016 312
2017 304
2018 289
2019 300
2020 335
2021 326
2022 343
2023 328
2024 140

Text availability

Article attribute

Article type

Publication date

Search Results

4,639 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for ezetrol
Your search for emetrol retrieved no results
Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia.
Lamb YN. Lamb YN. Am J Cardiovasc Drugs. 2020 Aug;20(4):381-392. doi: 10.1007/s40256-020-00421-1. Am J Cardiovasc Drugs. 2020. PMID: 32648167 Review.
Rosuvastatin/ezetimibe combines two lipid-lowering agents: rosuvastatin, an HMG-CoA reductase inhibitor (i.e. statin) with particularly strong inhibitory effects on hepatic cholesterol synthesis, and ezetimibe, which inhibits the intestinal absorption of cholesterol …
Rosuvastatin/ezetimibe combines two lipid-lowering agents: rosuvastatin, an HMG-CoA reductase inhibitor (i.e. statin) with particular …
Lipid Lowering Therapy: An Era Beyond Statins.
Abdul-Rahman T, Bukhari SMA, Herrera EC, Awuah WA, Lawrence J, de Andrade H, Patel N, Shah R, Shaikh R, Capriles CAA, Ulusan S, Ahmad S, Corriero AC, Mares AC, Goel A, Hajra A, Bandyopadhyay D, Gupta R. Abdul-Rahman T, et al. Curr Probl Cardiol. 2022 Dec;47(12):101342. doi: 10.1016/j.cpcardiol.2022.101342. Epub 2022 Jul 31. Curr Probl Cardiol. 2022. PMID: 35918009 Review.
These drugs include Bile acids sequestrants, Fibrates, Nicotinic acid, Ezetimibe, Bempedoic acid, Volanesoren, Evinacumab, and the PCSK 9 Inhibitors Evolocumab and Alirocumab. ...
These drugs include Bile acids sequestrants, Fibrates, Nicotinic acid, Ezetimibe, Bempedoic acid, Volanesoren, Evinacumab, and the PC …
Dyslipidemia Management in Pregnancy: Why Is It not Covered in the Guidelines?
Lewek J, Banach M. Lewek J, et al. Curr Atheroscler Rep. 2022 Jul;24(7):547-556. doi: 10.1007/s11883-022-01030-w. Epub 2022 Apr 30. Curr Atheroscler Rep. 2022. PMID: 35499807 Review.
RECENT FINDINGS: Among many available groups of lipid-lowering drugs, only bile acid sequestrants are approved for the treatment of dyslipidemia during pregnancy. Ezetimibe and fenofibrate might be considered if benefits outweigh the potential risk. ...
RECENT FINDINGS: Among many available groups of lipid-lowering drugs, only bile acid sequestrants are approved for the treatment of dyslipid …
Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis.
Tummala R, Gupta M, Devanabanda AR, Bandyopadhyay D, Aronow WS, Ray KK, Mamas M, Ghosh RK. Tummala R, et al. Ann Med. 2022 Dec;54(1):1287-1296. doi: 10.1080/07853890.2022.2059559. Ann Med. 2022. PMID: 35533049 Free PMC article. Review.
Studies have shown effectiveness in reducing LDL-C in both statin intolerant patients and in patients on maximally tolerated doses of statin. The fixed drug combination of bempedoic acid and ezetimibe in a recent phase III showed significant reduction in LDL compared with …
Studies have shown effectiveness in reducing LDL-C in both statin intolerant patients and in patients on maximally tolerated doses of statin …
Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights.
Chilbert MR, VanDuyn D, Salah S, Clark CM, Ma Q. Chilbert MR, et al. Drug Des Devel Ther. 2022 Jul 7;16:2177-2186. doi: 10.2147/DDDT.S332352. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35832642 Free PMC article. Review.
The recent approval of a combination tablet of high-intensity rosuvastatin and ezetimibe has introduced a potentially more beneficial option for cholesterol management in addition to the only available combination of moderate intensity simvastatin and ezetimibe. We …
The recent approval of a combination tablet of high-intensity rosuvastatin and ezetimibe has introduced a potentially more beneficial …
[Ezetimibe (Ezetrol): the statins' partner].
Ducobu J, Sternon J. Ducobu J, et al. Rev Med Brux. 2004 Oct;25(5):456-61. Rev Med Brux. 2004. PMID: 15584647 Review. French.
Combination therapy of ezetimibe with statins helped more patients in achieving their target LDL-C goal. Ezetimibe in coadministration with statins or alone had also favourable effects on triglycerides and HDL. ...
Combination therapy of ezetimibe with statins helped more patients in achieving their target LDL-C goal. Ezetimibe in coadmini …
Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention.
Lee SJ, Joo JH, Park S, Kim C, Choi DW, Hong SJ, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Nam CM, Hong MK. Lee SJ, et al. J Am Coll Cardiol. 2023 Aug 1;82(5):401-410. doi: 10.1016/j.jacc.2023.05.042. J Am Coll Cardiol. 2023. PMID: 37495276
BACKGROUND: The RACING (randomized comparison of efficacy and safety of lipid-lowering with statin monotherapy versus statin/ezetimibe combination for high-risk cardiovascular diseases) trial examined the effects of combination therapy with moderate-intensity statin and …
BACKGROUND: The RACING (randomized comparison of efficacy and safety of lipid-lowering with statin monotherapy versus statin/ezetimibe …
[Ezetimibe (Ezetrol) in patients with diabetes].
Scheen AJ, Radermecker RP. Scheen AJ, et al. Rev Med Liege. 2009 Dec;64(12):606-11. Rev Med Liege. 2009. PMID: 20143743 Free article. French.
Ezetimibe (Ezetrol) selectively inhibits the intestinal absorption of cholesterol and phytosterols. ...The present article aims at describing recent advances and specificities concerning the use of ezetimibe in the diabetic population....
Ezetimibe (Ezetrol) selectively inhibits the intestinal absorption of cholesterol and phytosterols. ...The present article aim …
[Statin intolerance].
Tonstad S. Tonstad S. Tidsskr Nor Laegeforen. 2017 Jan 10;137(1):36-38. doi: 10.4045/tidsskr.16.0646. eCollection 2017 Jan. Tidsskr Nor Laegeforen. 2017. PMID: 28073228 Free article. Review. Norwegian.
Fixed Combination for the Treatment of Dyslipidaemia.
Ferri N, Ruscica M, Santos RD, Corsini A. Ferri N, et al. Curr Atheroscler Rep. 2023 Oct;25(10):691-699. doi: 10.1007/s11883-023-01142-x. Epub 2023 Sep 16. Curr Atheroscler Rep. 2023. PMID: 37715044 Free PMC article. Review.
PURPOSE OF REVIEW: It is clear from epidemiological studies that patients at high and very-high risk of atherosclerotic cardiovascular diseases (ASCVD) risk do not reach lipid guideline-recommended targets. Thus, fixed-dose combinations of statins/ezetimibe, bempedoic acid …
PURPOSE OF REVIEW: It is clear from epidemiological studies that patients at high and very-high risk of atherosclerotic cardiovascular disea …
4,639 results